Advertisement

Associations among frailty and quality of life in older patients with cancer treated with chemotherapy

Published:August 22, 2022DOI:https://doi.org/10.1016/j.jgo.2022.08.010

      Abstract

      Introduction

      Previous studies have suggested that frailty among older adults with cancer is associated with a variety of negative outcomes, including greater chemotherapy toxicity and worse survival. However, results often do not include patient-reported outcomes, such as quality of life (QOL). The objective of this study was to evaluate frailty prior to receipt of moderately- or highly-emetogenic chemotherapy and acute changes in QOL in patients at least 65 years of age. It was hypothesized that frail patients would report greater declines in QOL.

      Materials and Methods

      Participants completed questionnaires before receiving their first infusion and again five days later. A 59-item deficit accumulation index score was created at baseline using a modified Rockwood frailty index. QOL was assessed using the Functional Assessment of Cancer Therapy-General (FACT-G). The relationship between baseline frailty and QOL was evaluated using a dichotomized deficit accumulation index (frail vs. robust) in repeated measures ANOVA.

      Results

      Study participants (n = 151) had a mean age of 72 (SD = 4.5) and 62% were female. Nearly half (42%) were frail at baseline. Frail participants reported worse QOL at baseline compared to robust participants. Frail patients reported smaller declines in overall and physical (p < 0.0001) and emotional (p = 0.006) QOL from baseline to five days after receiving chemotherapy. At five days, frail participants reported better emotional and physical QOL compared to robust participants.

      Discussion

      Contrary to expectations, frail patients reported smaller declines in QOL compared to robust patients using a deficit accumulation index. These results can be used to help educate frail patients on what to expect during treatment.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cinar D.
        • Tas D.
        Cancer in the elderly.
        North Clin Istanb. 2015; 2: 73-80
        • Smith B.D.
        • Smith G.L.
        • Hurria A.
        • Hortobagyi G.N.
        • Buchholz T.A.
        Future of cancer incidence in the United States: burdens upon an aging, changing nation.
        J Clin Oncol. 2009; 27: 2758-2765
        • Clegg A.
        • Young J.
        • Iliffe S.
        • Rikkert M.O.
        • Rockwood K.
        Frailty in elderly people.
        Lancet. 2013; 381: 752-762
        • Kennedy B.K.
        • Berger S.L.
        • Brunet A.
        • et al.
        Geroscience: linking aging to chronic disease.
        Cell. 2014; 159: 709-713
        • Ethun C.G.
        • Bilen M.A.
        • Jani A.B.
        • Maithel S.K.
        • Ogan K.
        • Master V.A.
        Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology.
        CA Cancer J Clin. 2017; 67: 362-377
        • Crocker T.F.
        • Brown L.
        • Clegg A.
        • et al.
        Quality of life is substantially worse for community-dwelling older people living with frailty: systematic review and meta-analysis.
        Qual Life Res. 2019; 28: 2041-2056
        • Williams G.R.
        • Deal A.M.
        • Sanoff H.K.
        • et al.
        Frailty and health-related quality of life in older women with breast cancer.
        Support Care Cancer. 2019; 27: 2693-2698
        • de Vries J.
        • Bras L.
        • Sidorenkov G.
        • et al.
        Frailty is associated with decline in health-related quality of life of patients treated for head and neck cancer.
        Oral Oncol. 2020; 111105020
        • Mandelblatt J.S.
        • Zhou X.
        • Small B.J.
        • et al.
        Deficit accumulation frailty trajectories of older breast Cancer survivors and non-Cancer controls: the thinking and living with Cancer study.
        J Natl Cancer Inst. 2021; 113: 1053-1064https://doi.org/10.1093/jnci/djab003
        • Hodes R.J.
        • Sierra F.
        • Austad S.N.
        • et al.
        Disease drivers of aging.
        Ann N Y Acad Sci. 2016; 1386: 45-68
        • Wildiers H.
        • Heeren P.
        • Puts M.
        • et al.
        International Society of Geriatric Oncology consensus on geriatric assessment in older patients with cancer.
        J Clin Oncol. 2014; 32: 2595-2603
        • Mohile S.G.
        • Dale W.
        • Somerfield M.R.
        • et al.
        Practical assessment and Management of Vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology.
        J Clin Oncol. 2018; 36: 2326-2347
        • Decoster L.
        • Van Puyvelde K.
        • Mohile S.
        • et al.
        Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendationsdagger.
        Ann Oncol. 2015; 26: 288-300
        • Verduzco-Aguirre H.C.
        • Navarrete-Reyes A.P.
        • Chavarri-Guerra Y.
        • Avila-Funes J.A.
        • Soto-Perez-de-Celis E.
        The effect of a geriatric oncology clinic on treatment decisions in Mexican older adults with Cancer.
        J Am Geriatr Soc. 2019; 67: 992-997
        • Flannery M.A.
        • Culakova E.
        • Canin B.E.
        • Peppone L.
        • Ramsdale E.
        • Mohile S.G.
        Understanding treatment tolerability in older adults with Cancer.
        J Clin Oncol. 2021; 39: 2150-2163
        • Ness K.K.
        • Wogksch M.D.
        Frailty and aging in cancer survivors.
        Transl Res. 2020; 221: 65-82
        • Atherton P.J.
        • Watkins-Bruner D.W.
        • Gotay C.
        • et al.
        The complementary nature of patient-reported outcomes and adverse event reporting in cooperative group oncology clinical trials: a pooled analysis (NCCTG N0591).
        J Pain Symptom Manage. 2015; 50: 470-479 e479
        • Bullinger M.
        • Quitmann J.
        Quality of life as patient-reported outcomes: principles of assessment.
        Dialogues Clin Neurosci. 2014; 16: 137-145
      1. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology Antiemesis. 2020. (Accessed July 16, 2021). chrome-extension://oemmndcbldboiebfnladdacbdfmadadm/https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf.

        • Cohen H.J.
        • Smith D.
        • Sun C.L.
        • et al.
        Frailty as determined by a comprehensive geriatric assessment-derived deficit-accumulation index in older patients with cancer who receive chemotherapy.
        Cancer. 2016; 122: 3865-3872
        • Rockwood K.
        • Howlett S.E.
        Fifteen years of progress in understanding frailty and health in aging.
        BMC Med. 2018; 16: 220
        • Kirkhus L.
        • Saltyte Benth J.
        • Rostoft S.
        • et al.
        Geriatric assessment is superior to oncologists’ clinical judgement in identifying frailty.
        Br J Cancer. 2017; 117: 470-477
        • Katz S.
        • Ford A.B.
        • Moskowitz R.W.
        • Jackson B.A.
        • Jaffe M.W.
        Studies of illness in the aged. The index of Adl: a standardized measure of biological and psychosocial function.
        JAMA. 1963; 185: 914-919
        • Ware Jr., J.
        • Kosinski M.
        • Keller S.D.
        A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity.
        Med Care. 1996; 34: 220-233
        • Yellen S.B.
        • Cella D.F.
        • Webster K.
        • Blendowski C.
        • Kaplan E.
        Measuring fatigue and other anemia-related symptoms with the functional assessment of Cancer therapy (FACT) measurement system.
        J Pain Symptom Manage. 1997; 13: 63-74
        • Searle S.D.
        • Mitnitski A.
        • Gahbauer E.A.
        • Gill T.M.
        • Rockwood K.
        A standard procedure for creating a frailty index.
        BMC Geriatr. 2008; 8: 24
        • Rockwood K.
        • Mitnitski A.
        Frailty in relation to the accumulation of deficits.
        J Gerontol A Biol Sci Med Sci. 2007; 62: 722-727
        • Rockwood K.
        • Song X.
        • MacKnight C.
        • et al.
        A global clinical measure of fitness and frailty in elderly people.
        CMAJ. 2005; 173: 489-495
        • Rockwood K.
        • Song X.
        • Mitnitski A.
        Changes in relative fitness and frailty across the adult lifespan: evidence from the Canadian National Population Health Survey.
        CMAJ. 2011; 183: E487-E494
        • Geessink N.
        • Schoon Y.
        • van Goor H.
        • Olde Rikkert M.
        • Melis R.
        • consortium T-M.
        Frailty and quality of life among older people with and without a cancer diagnosis: findings from TOPICS-MDS.
        PLoS One. 2017; 12: e0189648
        • Webster K.
        • Cella D.
        • Yost K.
        The functional assessment of chronic illness therapy (FACIT) measurement system: properties, applications, and interpretation.
        Health Qual Life Outcomes. 2003; 1: 79
        • Cella D.
        • Eton D.T.
        • Lai J.S.
        • Peterman A.H.
        • Merkel D.E.
        Combining anchor and distribution-based methods to derive minimal clinically important differences on the functional assessment of Cancer therapy (FACT) anemia and fatigue scales.
        J Pain Symptom Manage. 2002; 24: 547-561
        • Yost K.J.
        • Eton D.T.
        Combining distribution- and anchor-based approaches to determine minimally important differences: the FACIT experience.
        Eval Health Prof. 2005; 28: 172-191
        • Chen P.Y.
        • Yang C.M.
        Consequences of ignoring the response-shift and measure non-invariant items in sleep studies: an empirical data based simulation of the treatment effect of CBT-I on dysfunctional sleep beliefs.
        Sleep Med. 2020; 74: 99-108
        • Prigerson H.G.
        • Bao Y.
        • Shah M.A.
        • et al.
        Chemotherapy use, performance status, and quality of life at the end of life.
        JAMA Oncol. 2015; 1: 778-784
        • Jim H.S.
        • Jacobsen P.B.
        • Phillips K.M.
        • Wenham R.M.
        • Roberts W.
        • Small B.J.
        Lagged relationships among sleep disturbance, fatigue, and depressed mood during chemotherapy.
        Health Psychol. 2013; 32: 768-774
        • Jim H.S.
        • Small B.
        • Faul L.A.
        • Franzen J.
        • Apte S.
        • Jacobsen P.B.
        Fatigue, depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes.
        Ann Behav Med. 2011; 42: 321-333
        • Rockwood K.
        • Howlett S.E.
        Age-related deficit accumulation and the diseases of ageing.
        Mech Ageing Dev. 2019; 180: 107-116
        • Rockwood K.
        Conceptual models of frailty: accumulation of deficits.
        Can J Cardiol. 2016; 32: 1046-1050
        • Levit L.A.
        • Kaltenbaugh M.W.
        • Magnuson A.
        • et al.
        Challenges and opportunities to developing a frailty index using electronic health record data.
        J Geriatr Oncol. 2021; 12: 851-854
        • Fried L.P.
        • Tangen C.M.
        • Walston J.
        • et al.
        Frailty in older adults: evidence for a phenotype.
        J Gerontol A Biol Sci Med Sci. 2001; 56: M146-M156
        • Lewis E.G.
        • Coles S.
        • Howorth K.
        • et al.
        The prevalence and characteristics of frailty by frailty phenotype in rural Tanzania.
        BMC Geriatr. 2018; 18: 283
        • Pottel L.
        • Lycke M.
        • Boterberg T.
        • et al.
        Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life.
        Eur J Cancer Care (Engl). 2014; 23: 401-412
        • Goineau A.
        • Campion L.
        • d’Aillieres B.
        • et al.
        Comprehensive geriatric assessment and quality of life after localized prostate cancer radiotherapy in elderly patients.
        PLoS One. 2018; 13e0194173
        • Kirkhus L.
        • Saltyte Benth J.
        • Gronberg B.H.
        • et al.
        Frailty identified by geriatric assessment is associated with poor functioning, high symptom burden and increased risk of physical decline in older cancer patients: prospective observational study.
        Palliat Med. 2019; 33: 312-322
        • Ronning B.
        • Wyller T.B.
        • Nesbakken A.
        • et al.
        Quality of life in older and frail patients after surgery for colorectal cancer-a follow-up study.
        J Geriatr Oncol. 2016; 7: 195-200
        • Handforth C.
        • Clegg A.
        • Young C.
        • et al.
        The prevalence and outcomes of frailty in older cancer patients: a systematic review.
        Ann Oncol. 2015; 26: 1091-1101
        • Lachmann R.
        • Stelmach-Mardas M.
        • Bergmann M.M.
        • et al.
        The accumulation of deficits approach to describe frailty.
        PLoS One. 2019; 14e0223449
        • Magnuson A.
        • Lei L.
        • Gilmore N.
        • et al.
        Longitudinal relationship between frailty and cognition in patients 50 years and older with breast Cancer.
        J Am Geriatr Soc. 2019; 67: 928-936
        • Stull D.E.
        • Leidy N.K.
        • Parasuraman B.
        • Chassany O.
        Optimal recall periods for patient-reported outcomes: challenges and potential solutions.
        Curr Med Res Opin. 2009; 25: 929-942